Insider · CIK 0001790624

COLEMAN KIRK ALLEN

Reports to the SEC for 1 company · AUSTIN, TX

sec.gov

Transactions

Companies

Filings

CIK

0001790624

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-03	TFF Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+10.2K sh	—	—	45,859
2024-07-03	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+10.2K sh	—	—	10,184
2024-04-18	TFF Pharmaceuticals, Inc.Restricted stock unitsA Award	Chief Financial Officer	AAward	+10.6K sh	—	—	10,600
2024-04-18	TFF Pharmaceuticals, Inc.Restricted stock unitsA Award	Chief Financial Officer	AAward	+5,300 sh	—	—	5,300
2023-08-15	TFF Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+20K sh	$0.25	+$5,000	35,675
2023-03-22	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2023-03-10	TFF Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+12K sh	$0.79	+$9,457.2	15,675
2022-05-17	TFF Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+425 sh	$4.83	+$2,052.75	3,675
2022-05-16	TFF Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,250 sh	$4.40	+$5,500	3,250
2021-09-16	TFF Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,000 sh	$7.30	+$7,300	2,000
2021-03-15	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	277,883
2021-03-15	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$2.50	+$12.5K	6,000
2021-03-15	TFF Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$17.05	−$85.3K	1,000
2021-02-16	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	282,883
2021-02-16	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$2.50	+$12.5K	6,000
2021-02-16	TFF Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$16.82	−$84.1K	1,000
2021-01-15	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$2.50	+$12.5K	6,000
2021-01-15	TFF Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$17.50	−$87.5K	1,000
2021-01-15	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	287,883
2020-12-23	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	292,883
2020-12-23	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$2.50	+$25K	11,000
2020-12-23	TFF Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$15.24	−$152K	1,000
2020-11-10	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	302,883
2020-11-10	TFF Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$15.12	−$227K	1,000
2020-11-10	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15K sh	$2.50	+$37.5K	16,000
2020-08-24	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	317,883
2019-12-20	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	277,883
2019-11-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+5,920 sh	—	—	227,883
2019-10-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+72K sh	—	—	221,963
2019-10-25	TFF Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,000 sh	$5.00	+$5,000	1,000

Recent filings

Accepted (ET)
Jul 84
COLEMAN KIRK ALLEN0001213900-24-059874
SEC(opens sec.gov)
Apr 224
COLEMAN KIRK ALLEN0001213900-24-035080
SEC(opens sec.gov)
Aug 154
COLEMAN KIRK ALLEN0001213900-23-067441
SEC(opens sec.gov)
Mar 244
COLEMAN KIRK ALLEN0001213900-23-022878
SEC(opens sec.gov)
Mar 134
COLEMAN KIRK ALLEN0001213900-23-019387
SEC(opens sec.gov)
May 174
COLEMAN KIRK ALLEN0001213900-22-027793
SEC(opens sec.gov)
Sep 164
COLEMAN KIRK ALLEN0001213900-21-048367
SEC(opens sec.gov)
Mar 174
COLEMAN KIRK ALLEN0001213900-21-016182
SEC(opens sec.gov)
Feb 184
COLEMAN KIRK ALLEN0001213900-21-010414
SEC(opens sec.gov)
Jan 204
COLEMAN KIRK ALLEN0001213900-21-003296
SEC(opens sec.gov)
Dec 294
COLEMAN KIRK ALLEN0001213900-20-045176
SEC(opens sec.gov)

Companies

TFF Pharmaceuticals, Inc.Chief Financial Officer

Address

2600 VIA FORTUNA, SUITE 360

AUSTIN, TX, 78746